Aptevo Therapeutics Inc.

NASDAQ: APVO · Real-Time Price · USD
1.99
-0.05 (-2.45%)
At close: Aug 15, 2025, 3:05 PM

Aptevo Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.05 -0.13 1.47 -1.35
PEG Ratio
0.00 0.00 -0.01 0.04
PS Ratio
n/a n/a 3.80 3.00
PB Ratio
0.25 0.18 0.66 30.34
P/FCF Ratio
-0.05 -0.19 -0.56 -1.65
P/OCF Ratio
-0.05 -0.19 -0.56 -1.7
OCF/S Ratio
n/a n/a -6.75 -1.76
Debt / Equity Ratio
0.97 0.44 0.53 13.75
Quick Ratio
1.72 2.64 2.97 1.42
Current Ratio
1.72 2.64 3.15 1.51
Asset Turnover
n/a n/a 0.09 0.22
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-5.07 -1.42 0.45 -22.46
Return on Assets
-1.55 -0.7 0.23 -0.48
Return on Invested Capital
-2.62 -1.64 -1.04 -0.59
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -4.74 -0.55
Net Profit Margin
n/a n/a 2.58 -2.22
Pretax Profit Margin
n/a n/a 2.25 -2.39
Operating Profit Margin
n/a n/a -9.2 -1.74
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -8.91 -1.65